ArticleDiabetology international2017

Effects of ipragliflozin, a selective sodium-glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus: a pooled analysis of six randomized, placebo-controlled clinical trials.

Atsunori Kashiwagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.